Analyst Price Targets — LFMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 27, 2026 10:49 am | Yi Chen | H.C. Wainwright | $10.00 | $4.24 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on LifeMD Inc (LFMD) |
| March 12, 2026 2:07 pm | Ilya Zubkov | Loop Capital Markets | $10.00 | $3.88 | StreetInsider | LifeMD Inc (LFMD) PT Raised to $10 at Freedom Capital Markets |
| November 24, 2025 7:41 pm | Ilya Zubkov | Loop Capital Markets | $8.00 | $3.97 | StreetInsider | LifeMD Inc (LFMD) PT Lowered to $8 at Freedom Capital Markets |
| November 19, 2025 1:33 pm | Steven Valiquette | Mizuho Securities | $6.00 | $3.99 | TheFly | LifeMD price target lowered to $6 from $8 at Mizuho |
| November 19, 2025 11:31 am | Scott Schoenhaus | KeyBanc | $8.00 | $3.99 | TheFly | LifeMD price target lowered to $8 from $12 at KeyBanc |
| November 18, 2025 11:49 am | — | BTIG | $10.00 | $4.09 | TheFly | LifeMD price target lowered to $10 from $18 at BTIG |
| July 10, 2025 12:46 pm | Brooks O'Neil | Lake Street | $18.00 | $11.81 | TheFly | LifeMD price target raised to $18 from $12 at Lake Street |
| March 12, 2025 10:11 am | Yi Chen | H.C. Wainwright | $14.00 | $5.58 | TheFly | LifeMD price target raised to $14 from $12 at H.C. Wainwright |
| January 8, 2025 12:05 pm | Scott Schoenhaus | KeyBanc | $7.00 | $5.54 | TheFly | LifeMD price target lowered to $7 from $10 at KeyBanc |
| December 10, 2024 12:49 pm | Brooks O'Neil | Lake Street | $12.00 | $5.97 | TheFly | LifeMD initiated with a Buy at Lake Street |
Latest News for LFMD
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend to holders of the Company's 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on July 15, 2026, to holders of record at the close of…
Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing arrangement with LifeMD for the XYOSTED self-pay program, launching in July 2026 in 37 states
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of Umesh Sripad as Chief Technology Officer (CTO), effective immediately. In this role, Mr. Sripad will lead LifeMD's technology strategy, platform transformation, AI enablement, cybersecurity, data infrastructure, and enterprise scalability initiatives as the…
Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD's Next Phase of Growth
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that management will be participating in two upcoming investor conferences.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LFMD.
U.S. House Trading
No House trades found for LFMD.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.